» Articles » PMID: 39716126

Analysis of Uric Acid and High-density Lipoprotein Levels in Refractory Posner-schlossman Syndrome Patients: a Matched Case-control Study by the Propensity Score

Overview
Journal BMC Ophthalmol
Publisher Biomed Central
Specialty Ophthalmology
Date 2024 Dec 23
PMID 39716126
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recent studies have indicated that oxidative stress is a crucial pathophysiological process in glaucoma. We hypothesized that Posner-Schlossman syndrome (PSS) is a vascular inflammation in the ciliary body due to oxidative stress and endothelial dysfunction. Thus, we investigated serum uric acid (UA) and lipid levels in patients with refractory PSS with the aim of providing basic evidence for the mechanism of PSS.

Methods: This is a retrospective, case-control study. A total of 81 refractory PSS and 409 control participants were included in this study. Clinical and laboratory characteristics were reviewed using an electronic medical system. Propensity score-matched (PSM) analysis was performed to reduce demographic differences. The t-test, Mann-Whitney U test, and χ2 test were used to assess the differences between the PSS and control groups. Logistic regression analysis was used to identify the predictors of PSS.

Results: The higher serum UA (364.14 ± 98.72µmol/L vs. 322.38 ± 72.09µmol/L), higher low-density lipoprotein (LDL) / High-density lipoprotein (HDL) ratio (2.50 ± 0.97 vs. 1.95 ± 0.72) and lower HDL (1.29 ± 0.32 mmol/L vs. 1.59 ± 0.38 mmol/L) can be noticed in refractory PSS than control group. Logistics regression identified UA > 420 µmol/L (OR = 4.461) and the HDL < 1.03 mmol/L (OR = 3.896) were the independent risk factors for refractory PSS.

Conclusions: Increasing serum UA and decreasing HDL levels were positively correlated with the incidence risk of refractory PSS. Further prospective longitudinal studies and animal models are needed.

References
1.
Serra R, Coscas F, Pinna A, Peri M, Zucca I, Sellam A . Detection of serum uric acid in primary open angle glaucoma: A pilot study. Eur J Ophthalmol. 2020; 31(4):1857-1861. DOI: 10.1177/1120672120944012. View

2.
Maruyama K, Maruyama Y, Sugita S, Mori K, Yokoyama Y, Sanuki-Kunimatsu S . Characteristics of cases needing advanced treatment for intractable Posner-Schlossman syndrome. BMC Ophthalmol. 2017; 17(1):45. PMC: 5387341. DOI: 10.1186/s12886-017-0438-y. View

3.
Baillie J, Bates M, Thompson A, Waring W, Partridge R, Schnopp M . Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitude. Chest. 2007; 131(5):1473-8. DOI: 10.1378/chest.06-2235. View

4.
Rader D, Hovingh G . HDL and cardiovascular disease. Lancet. 2014; 384(9943):618-625. DOI: 10.1016/S0140-6736(14)61217-4. View

5.
Lee T, Lu T, Chen C, Guo B, Hsu C . Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway. Redox Biol. 2021; 46:102108. PMC: 8390558. DOI: 10.1016/j.redox.2021.102108. View